Slide 1: Evolving stronger, growing together
Evolving stronger, growing together Analyst presentation 2025 half-year results 30 July 2025
Slide 2: Presenting team
Presenting team Marcus Jordan Hans Kooijmans CEO CFO 2
Slide 3: Highlights HY 2025, Financials HY 2025, Outlook, Q&A, Annex
1 Highlights HY 2025 2 Financials HY 2025 3 Outlook 4 Q&A 5 Annex 3
Slide 4: Highlights HY 2025: Financial results
Highlights HY 2025: Financial results Cash earnings Gross profit Operating EBITA Net Result Free cash flow per share EUR 634 million EUR 275 million EUR 130 million EUR 173 million EUR 2.94 +7% on a constant +4% on a constant -7% on a constant H1 2024: EUR 221 H1 2024: EUR 3.23 currency basis curren
Slide 5: Highlights HY 2025: M&A
Highlights HY 2025: M&A EMEA ● Tecom (Spain) – Food and nutrition (signed May 2025, closed July 2025) ● Ferrer (Spain) – Food and nutrition (signed and closed June 2025) Americas ● Apus Química (Chili) – Advanced materials (signed June 2025, closed July 2025) ● Trichem (India) – Pharmaceutical marke
Slide 6: Continued focus on the six strategic pillars that drive our growth
Continued focus on the six strategic pillars that drive our growth • 14 training hrs – on track to achieve our goal of 30 hrs average training • 6 acquisitions completed across per employee by 2030 segments and regions • SalesAssistant internally rolled out • Further strengthening of supplier global
Slide 7: Financials HY 2025
Highlights Financials Outlook Q&A Annex HY 2025 HY 2025
Slide 8: Financials HY 2025 – income statement
Financials HY 2025 – income statement Jan. 1 - Jun. 30 Jan. 1 - Jun. 30 Fx. adj. EUR million 2025 2024 Change Change % change Revenue 2,474 2,385 89 4% 6% Gross profit 634 607 27 5% 7% Gross profit as a % of revenue 25.6% 25.4% 0.2% Operating EBITA1 275 270 5 2% 4% Operating EBITA as a % or revenue
Slide 9: Financials HY 2025 – segment information
Financials HY 2025 – segment information Asia- Holding EUR million EMEA Americas Pacific companies Total Gross profit HY 2025 293 191 150 634 HY 2024 286 180 140 607 organic growth 2% 4% 5% 3% acquisition growth 1% 7% 5% 4% currency impact (1%) (5%) (3%) (2%) Operating EBITA HY 2025 124 83 86 (18) 2
Slide 10: Financials HY 2025 – income statement
Financials HY 2025 – income statement Jan. 1 - Jun. 30 Jan. 1 - Jun. 30 Fx. adj. EUR million 2025 2024 Change Change % change Operating EBITA 275 270 5 2% 4% Net finance costs (44) (27) (17) Amortisation of intangible assets (50) (47) (3) Acquisition costs/one-off adjustments - (7) (3) (4) income an
Slide 11: Financials HY 2025 – net finance costs
Financials HY 2025 – net finance costs Jan. 1 - Jun. 30 Jan. 1 - Jun. 30 EUR million 2025 2024 Change Interest costs financing structure (27) (29) 2 Interest costs lease liabilities (2) (2) - Amortisation of finance costs (1) (1) - Changes in deferred considerations 7 14 (7) Interest costs re employ
Slide 12: Financials HY 2025 – balance sheet
Financials HY 2025 – balance sheet EUR million 30/06/2025 31/12/2024 Change 30/06/2024 Property, plant and equipment 134 145 (11) 151 Intangible assets 2,576 2,609 (33) 2,504 Other financial assets/deferred tax assets 54 55 (1) 50 Total working capital 963 907 56 843 Provisions/employee benefits (45
Slide 13: Financials HY 2025 – year-end working capital
Financials HY 2025 – year-end working capital EUR m 30/06/2025 31/12/2024 30/06/2024 756 642 722 846 747 851 70 75 64 (563) (478) (554) (146) (158) (161) EUR million 30/06/2025 31/12/2024 30/06/2024 Inventories in days of revenue1 54 55 48 Trade receivables in days of revenue1 60 57 64 Trade payable
Slide 14: Financials HY 2025 – net debt
Financials HY 2025 – net debt EUR million 30/06/2025 31/12/2024 Change 30/06/2024 Maturity profile as of 30/06/2025 EUR m Loans and borrowings long term 1,381 1,397 (16) 1,240 1,200 Loans and borrowings short term - 300 (300) - 1,000 Short term financial liabilities 352 110 242 573 800 Cash and cash
Slide 15: Financials HY 2025 – free cash flow
Financials HY 2025 – free cash flow EUR million 30/06/2025 30/06/2024 Change Operating EBITA 275 270 5 Depreciation 20 20 - Operating EBITDA 295 290 5 Lease payments (16) (15) (1) Share based payments 2 2 - Adjusted operating EBITDA 281 277 4 Capex (5) (6) 1 ∆ Working capital1 (103) (50) (53) Free c
Slide 16: Outlook
Highlights Financials Outlook Q&A Annex HY 2025 HY 2025
Slide 17: Outlook
Outlook IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Results can be influ
Slide 18: Q&A
Highlights Financials Outlook Q&A Annex HY 2025 HY 2025
Slide 19: Annex
Highlights Financials Outlook Q&A Annex HY 2025 HY 2025
Slide 20: We are IMCD
We are IMCD IMCD is a leading global partner for the distribution and formulation of speciality chemicals and ingredients ● Adaptable business model driving simplification for our partners ● Formulatory and solutions provider ● Comprehensive and complementary specialty portfolio ● Global footprint w
Slide 21: 8 Business Groups focusing on strategic market segments
8 Business Groups focusing on strategic market segments Pharmaceuticals Coatings & Construction Food & Nutrition Advanced Materials Excipients; APIs; Coatings; decorative paints; Dairy; savoury; bakery; Compounders; converters; nutraceuticals; synthesis; adhesives & sealants; textile & beverage; ani
Slide 22: High scores on external ESG ratings
High scores on external ESG ratings Demonstrating our continuous focus on best practices Score B (2024) Platinum (2025) Score B (2023) Gold (2024) On a scale of A to D- ESG Risk Rating 11.6, low risk (2025) C+ (Prime) rating 12.6 (2024) C rating (2023) On a scale of A+ to D- 22
Slide 23: Disclaimer
Disclaimer This presentation may contain forward looking statements. These statements are based on current expectations, estimates and projections of IMCD’s management and information currently available to the company. IMCD cautions that such statements contain elements of risk and uncertainties th